| Deubiquitinase MYSM1 in the hematopoietic system and beyond: a current review A Fiore, Y Liang, YH Lin, J Tung, HC Wang, D Langlais, A Nijnik International Journal of Molecular Sciences 21 (8), 3007, 2020 | 28 | 2020 |
| Pre-existing chromatin accessibility and gene expression differences among naive CD4+ T cells influence effector potential D Rogers, A Sood, HC Wang, JJP van Beek, TJ Rademaker, P Artusa, ... Cell Reports 37 (9), 2021 | 25 | 2021 |
| Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation … D Farge, S Loisel, M Resche-Rigon, P Lansiaux, I Colmegna, D Langlais, ... The Lancet Rheumatology 4 (2), e91-e104, 2022 | 22 | 2022 |
| Comprehensive human amniotic fluid metagenomics supports the sterile womb hypothesis HC Wang, GX Yang, Y Hu, P Lam, K Sangha, D Siciliano, A Swenerton, ... Scientific Reports 12 (1), 6875, 2022 | 20 | 2022 |
| p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress LT Tung, HC Wang, JI Belle, JC Petrov, D Langlais, A Nijnik Cell Death & Disease 12 (10), 923, 2021 | 18 | 2021 |
| MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction JI Belle, HC Wang, A Fiore, JC Petrov, YH Lin, CH Feng, TTM Nguyen, ... JCI insight 5 (13), 2020 | 16 | 2020 |
| Regulation of B lymphocyte development by histone H2A deubiquitinase BAP1 YH Lin, Y Liang, HC Wang, LT Tung, M Förster, PG Subramani, ... Frontiers in immunology 12, 626418, 2021 | 13 | 2021 |
| Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma YH Lin, HC Wang, A Fiore, M Förster, LT Tung, JI Belle, F Robert, ... Journal of Cellular and Molecular Medicine 25 (14), 7089-7094, 2021 | 10 | 2021 |
| USP44 is dispensable for normal hematopoietic stem cell function, lymphocyte development, and B-cell-mediated immune response in a mouse model YH Lin, M Forster, Y Liang, M Yu, HC Wang, F Robert, D Langlais, ... Experimental Hematology 72, 1-8, 2019 | 9 | 2019 |
| A forward genetic screen identifies modifiers of rocaglate responsiveness L Shen, L Pugsley, R Cencic, HC Wang, F Robert, SK Naineni, A Sahni, ... Scientific Reports 11 (1), 18516, 2021 | 3 | 2021 |
| Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development Y Liang, G Bhatt, LT Tung, HC Wang, JE Kim, M Mousa, V Plackoska, ... Scientific Reports 13 (1), 338, 2023 | 2 | 2023 |
| Histone H2A deubiquitinases in the transcriptional programs of development and hematopoiesis: a consolidated analysis HC Wang, D Langlais, A Nijnik The International Journal of Biochemistry & Cell Biology 157, 106384, 2023 | 1 | 2023 |
| B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1 Y Liang, HC Wang, N Seija, YH Lin, LT Tung, JM Di Noia, D Langlais, ... Frontiers in Immunology 15, 1353138, 2024 | | 2024 |
| Chromatin‐binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation M Mousa, Y Liang, LT Tung, HC Wang, C Krawczyk, D Langlais, A Nijnik Immunology, 2024 | | 2024 |
| Evaluation of Tavakol et al.: Harnessing organs-on-a-chip to model tissue regeneration S Abbasi, A Adoungotchodo, U Ansari, M Baghdadi, K Baral, O Bashth, ... Cell Stem Cell 28 (6), 979-982, 2021 | | 2021 |
| The transcriptional regulation by MYSM1 in hematopoietic stem and progenitor cells HC Wang McGill University (Canada), 2020 | | 2020 |
David LanglaisAssociate Professor, McGill UniversityVerified email at mcgill.ca
